Molecular Level Radiopharmaceutical Cancer Care

In cancer care, one size never fits all. Every person is unique and deserves a treatment plan tailored specifically to that individual. Using advanced analytics, we’ll create an individualized, precise treatment plan using next-generation radiopharmaceuticals. Though our approach is high-tech, it comes with a warm, personal, and empathetic touch.

What Is Theranostics?

The term “theranostics” is simply a combination of therapeutic and diagnostics that allows us to find cancer cells, and then use the same or similar molecules to eliminate them. We utilize PET scans to visualize and highlight tumors, SPECT scans to dynamically monitor the effect of therapy, and radiopharmaceuticals to treat the cancer.

Putting Cancer In The Crosshairs

At United Theranostics, we’re redefining the clinical practice of molecular imaging and precision radiopharmaceutical therapy, from mere availability to meaningful accessibility.

Our Center of Excellence® clinics combine the best available clinical evidence from medical journals and our own data with your individual biologic profile, personal preferences and values.

We tailor treatment to your specific needs and are committed to empowering you in the process of your care

Clinical Trials

United Theranostics is committed to advancing cancer care through ongoing clinical trials and research partnerships. Our facilities offer patients access to innovative radiopharmaceutical therapies and next-generation treatment options for metastatic prostate cancer, metastatic neuroendocrine cancer, thyroid cancer, and other malignancies. By collaborating with leading healthcare institutions, we ensure that patients benefit from the latest breakthroughs in precision medicine and personalized cancer treatment.

A Supportive Setting

Before, during and after treatment, we collaborate with your oncologists, urologists and other referring providers. When you arrive at our clinic, you’ll find a supportive, comfortable outpatient setting that lets us deliver targeted therapies.